Spineart announced completion of 1,000 Scarlet® AC-T surgeries in the U.S. The system received FDA 510(k) market clearance in 4Q14.
Scarlet AC-T is Spineart's first standalone cervical device, comprising titanium cage and screws. The locking mechanism of the screw head is completely integrated within the cage, to reduce the profile and potential risks associated with dysphagia. As with all of Spineart's products, implants are provided sterile with one compact instrument set.